Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis

被引：0

作者：

Kalincik, T. ^{[1
]}

Jokubaitis, V. ^{[2
]}

Spelman, T. ^{[2
]}

Horakova, D. ^{[3
,4
,5
]}

Havrdova, E. ^{[3
,4
,5
]}

Trojano, M. ^{[6
]}

Lechner-Scott, J. ^{[7
]}

Lugaresi, A. ^{[8
]}

Prat, A. ^{[9
]}

Girard, M. ^{[9
]}

Duquette, P. ^{[9
]}

Grammond, P. ^{[10
]}

Solaro, C. ^{[11
]}

Grand'Maison, F. ^{[12
]}

Hupperts, R. ^{[13
]}

Prevost, J. ^{[14
]}

Sola, P. ^{[15
]}

Ferraro, D. ^{[15
]}

Terzi, M. ^{[16
]}

Butler, E. ^{[17
]}

Slee, M. ^{[18
]}

Kermode, A. ^{[19
]}

Fabis-Pedrini, M. ^{[19
]}

McCombe, P. ^{[20
]}

Barnett, M. ^{[21
]}

Shaw, C. ^{[22
]}

Hodgkinson, S. ^{[23
]}

Butzkueven, H. ^{[2
]}

机构：

[1] Royal Melbourne Hosp, Dept Neurol, CORe, Melbourne, Vic, Australia

[2] Univ Melbourne, Dept Med, Melbourne, Vic, Australia

[3] Gen Univ Hosp, Dept Neurol, Prague, Czech Republic

[4] Gen Univ Hosp, Ctr Clin Neurosci, Prague, Czech Republic

[5] Charles Univ Prague, Fac Med 1, Prague, Czech Republic

[6] Univ Bari, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy

[7] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW, Australia

[8] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy

[9] Hop Notre Dame De Bon Secours, Montreal, PQ, Canada

[10] CISSS Chaudiere Appalache, Levis, PQ, Canada

[11] Osped PA Micone, Genoa, Italy

[12] Neuro Rive Sud, Quebec City, PQ, Canada

[13] Zuyderland Ziekenhuis, Sittard, Netherlands

[14] CSSS St JErUme, St Jerome, PQ, Canada

[15] Univ Modena, Dept Biomed Metab & Neurosci, Modena, Italy

[16] 19 Mayis Univ, Fac Med, Samsun, Turkey

[17] Monash Med Ctr, Melbourne, Vic, Australia

[18] Flinders Univ S Australia, Adelaide, SA, Australia

[19] Univ Western Australia, Perth, WA, Australia

[20] Univ Queensland, Brisbane, Qld, Australia

[21] Univ Sydney, Brain & Mind Ctr, Sydney, NSW, Australia

[22] Geelong Hosp, Geelong, Vic, Australia

[23] Liverpool Hosp, Sydney, NSW, Australia

来源：

MULTIPLE SCLEROSIS JOURNAL | 2017年 / 23卷

基金：

加拿大健康研究院;

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P1138

引用

页码：596 / 597

页数：2

共 50 条

[31] Multiple Sclerosis in Childhood and Adolescence: Fingolimod versus Interferon beta-1a
Lorenz, Judith
FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2019, 87 (04) : 210 - 210
[32] Dengue fever in patients with multiple sclerosis taking fingolimod or natalizumab
Fragoso, Yara Dadalti
da Gama, Paulo Diniz
Gomes, Sidney
Netto Khouri, Jussara Mathias
da Cunha Matta, Andre Palma
Mendes, Maria Fernanda
Aparecida Vieira Stella, Carla Renata
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2016, 6 : 64 - 65
[33] Treating multiple sclerosis with fingolimod or intramuscular interferon
Pozzilli, Carlo
Prosperini, Luca
Borriello, Giovanna
EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (11) : 1957 - 1960
[34] Comparative Effectiveness of Cladribine versus Fingolimod in the Treatment of Highly Active Relapsing Multiple Sclerosis: The MERLYN Study
Brownlee, W.
Haghikia, A.
Hayward, B.
Waser, N.
Kayaniyil, S.
Khan, Z.
Duncan, J.
Millar, S.
Harty, G.
MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 63 - 63
[35] Risk of fingolimod rebound after switching to cladribine or rituximab in multiple sclerosis
Nygaard, Gro Owren
Torgauten, Hilde
Skattebol, Lars
Hogestol, Einar August
Sowa, Piotr
Myhr, Kjell-Morten
Torkildsen, Oivind
Celius, Elisabeth Gulowsen
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 62
[36] Neurometabolic changes in multiple sclerosis: Fingolimod versus beta interferon or glatiramer acetate therapy
Al-iedani, Oun
Lea, Rodney
Ribbons, Karen
Ramadan, Saadallah
Lechner-Scott, Jeannette
JOURNAL OF NEUROIMAGING, 2022, 32 (06) : 1109 - 1120
[37] Predictors for multiple sclerosis relapses after switching from natalizumab to fingolimod
Hoepner, Robert
Havla, Joachim
Eienbroeker, Christian
Tackenberg, Bjoern
Hellwig, Kerstin
Meinl, Ingrid
Hohlfeld, Reinhard
Gold, Ralf
Kuempfel, Tania
Kleiter, Ingo
MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (13) : 1714 - 1720
[38] Fingolimod/natalizumabReactivation of multiple sclerosis following natalizumab withdrawal: case report
Reactions Weekly, 2013, 1433 (1) : 22 - 22
[39] Switching From Natalizumab to Fingolimod in Multiple Sclerosis A French Prospective Study
Cohen, Mikael
Maillart, Elisabeth
Tourbah, Ayman
De Seze, Jerome
Vukusic, Sandra
Brassat, David
Anne, Olivier
Wiertlewski, Sandrine
Camu, William
Courtois, Vie
Ruet, Aurelie
Debouverie, Marc
Le Page, Emmanuelle
Casez, Olivier
Heinzlef, Olivier
Stankoff, Bruno
Bourre, Bertrand
Castelnovo, Giovanni
Rico, Audrey
Berger, Eric
Camdessanche, Jean-Philippe
Defer, Gilles
Clavelou, Pierre
Al Khedr, Abdullatif
Zephir, Helene
Fromont, Agnes
Papeix, Caroline
Brochet, Bruno
Pelletier, Jean
Lebrun, Christine
JAMA NEUROLOGY, 2014, 71 (04) : 436 - 441
[40] Moving to Fingolimod From Natalizumab in Multiple Sclerosis: The ENIGM Is Not Solved Reply
Cohen, Mikael
Lebrun, Christine
JAMA NEUROLOGY, 2014, 71 (07) : 925 - 925

← 1 2 3 4 5 →